Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to $1.3 billion for Verve Therapeutics Inc., the maker of a new gene-editing treatment, Lilly said on Tuesday.

Rocket Lab Corporation (NASDAQ:RKLB) is among the best NASDAQ stocks under $50 to buy Analysts at Cantor Fitzgerald have ...

Financial services firm Cantor Fitzgerald has initiated coverage for public companies with Solana treasuries. In a note to ...

Pfizer Inc. (NYSE:PFE) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald reaffirmed ...

Cantor Fitzgerald remains cautiously optimistic on U.S. equities, noting that the market currently sits near the upper end of ...

SOL fell to $149.46 Tuesday after a late-evening sell-off erased earlier gains, though some institutional analysts continue ...

Cantor Fitzgerald’s latest report positions Solana as a prime corporate treasury asset, citing staking rewards and ...

Rund 15 Banker des Frankfurter Geldhauses Hauck Aufhäuser Lampe (HAL) wechseln zum US-Konkurrenten Cantor Fitzgerald. Dieser ...

Hong Kong’s MemeStrategy has bought its first stack of Solana — $368,820 worth — and has committed to supporting network ...

A Wall Street analyst says Solana is becoming more useful in finance and could help certain companies grow fast.

Cantor Fitzgerald predicts potential 75% stock price increases for companies holding Solana reserves, such as DFDV, UPXI, and ...